
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Reports: Germany plans expansion of foreign intelligence powers - 2
The Manual for Well known rough terrain Vehicles - 3
NASA probe captures stunning photos of Earth and moon on the way to infamous asteroid Apophis - 4
Best Amusement Park Bite: What Do You Very much want to Crunch On? - 5
How effective is the flu shot this year? New report shows promising results
More than 800 flights canceled as FAA cuts traffic at 40 major airports. Here's what to know.
Reconnecting with an old friend is a story of distance, loss and rediscovery
Steinmeier honours Italian 'guest workers' who rebuilt German economy
‘I love this work, but it’s killing me’: The unique toll of being a spiritual leader today
Israel violated ceasefire with Hezbollah more than 10,000 times, UNIFIL claims
Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
Venezuelan President Maduro arrives in New York following U.S. capture: Full coverage
10 Energizing Vocations in the Innovation Business












